CompaniesSkyline Biosciences

Skyline Biosciences

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

By Phase

PHASE1: 1

By Status

WITHDRAWN: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
Today
NCT03939364
Hover over trial bars to see details

Recent Trials

NCT03939364Lead Sponsor
This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesions
PHASE1Withdrawn
Started: Jan 31, 2022 · Completed: May 31, 2023
Skyline Biosciences | Biotech Hunter | Biotech Hunter